Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Multiple Myeloma”

364 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 364 results

Not applicableStudy completedNCT03602755
What this trial is testing

The First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

Who this might be right for
Multiple Myeloma
Celgene 706
Not applicableUnknownNCT03122327
What this trial is testing

CGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.

Who this might be right for
Multiple MyelomaComprehensive Geriatric Assessment
Peking Union Medical College Hospital 200
Testing effectiveness (Phase 2)UnknownNCT03188172
What this trial is testing

MUK Nine b: OPTIMUM Treatment Protocol

Who this might be right for
Multiple Myeloma
University of Leeds 95
Testing effectiveness (Phase 2)UnknownNCT05712083
What this trial is testing

BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Zhejiang University 40
Not applicableUnknownNCT05218603
What this trial is testing

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Who this might be right for
Multiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT)
PETHEMA Foundation 100
Large-scale testing (Phase 3)UnknownNCT01532856
What this trial is testing

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 64
Not applicableUnknownNCT03089411
What this trial is testing

Collection of Additional Data Followed the Study IFM 2013-04

Who this might be right for
Myeloma Multiple
Nantes University Hospital 340
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Not applicableStudy completedNCT00907452
What this trial is testing

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

Who this might be right for
Myeloma
Intergroupe Francophone du Myelome 143
Large-scale testing (Phase 3)Study completedNCT05804032
What this trial is testing

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 514
Testing effectiveness (Phase 2)UnknownNCT01114048
What this trial is testing

Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 78
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Early research (Phase 1)Looking for participantsNCT07333261
What this trial is testing

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Susan Bal 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07600151
What this trial is testing

Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma

Who this might be right for
Myeloma MultipleMyeloma
Universitätsklinikum Hamburg-Eppendorf 220
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Testing effectiveness (Phase 2)Study completedNCT02843074
What this trial is testing

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 53
Large-scale testing (Phase 3)UnknownNCT00910897
What this trial is testing

Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 205
Large-scale testing (Phase 3)Study completedNCT01093196
What this trial is testing

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 660
Not applicableLooking for participantsNCT06099912
What this trial is testing

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

Who this might be right for
Multiple MyelomaFrailty
FengYan Jin 131
Testing effectiveness (Phase 2)UnknownNCT03695744
What this trial is testing

Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma
Singapore General Hospital 27
Load More Results